Sygdomsmekanismer og nye behandlingsmetoder ved migræne

Jakob Møller Hansen; Messoud Ashina

Sygdomsmekanismer og nye behandlingsmetoder ved migræne

Translated title of the contribution: Basic mechanisms of migraine and new methods of treatment

Department of Neurology

Abstract

Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.

Translated title of the contribution	Basic mechanisms of migraine and new methods of treatment
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	178
Issue number	51
Pages (from-to)	V07160507
ISSN	0041-5782
Publication status	Published - 19 Dec 2016

Cite this

@article{76ba6874c0704740b797650609f76811,

title = "Sygdomsmekanismer og nye behandlingsmetoder ved migr{\ae}ne",

abstract = "Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.",

author = "Hansen, \{Jakob M{\o}ller\} and Messoud Ashina",

year = "2016",

month = dec,

day = "19",

language = "Dansk",

volume = "178",

pages = "V07160507",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "51",

}

TY - JOUR

T1 - Sygdomsmekanismer og nye behandlingsmetoder ved migræne

AU - Hansen, Jakob Møller

AU - Ashina, Messoud

PY - 2016/12/19

Y1 - 2016/12/19

N2 - Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.

AB - Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.

UR - https://www.scopus.com/pages/publications/85056692419

M3 - Tidsskriftartikel

C2 - 28041540

SN - 0041-5782

VL - 178

SP - V07160507

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 51

ER -

Sygdomsmekanismer og nye behandlingsmetoder ved migræne

Abstract

Other files and links

Fingerprint

Cite this